1st Floor, 5.08
King Abdullah Financial District
Riyadh, Saudi Arabia
Our Office is open Sunday-Thursday from 9 AM to 5PM
Frequently Asked Questions
What is Hevolution Foundation?
Hevolution Foundation is a global non-profit organization focused on advancing healthspan science. Launched in 2021 and headquartered in Riyadh, Saudi Arabia, Hevolution supports research, grants, partnerships, and early-stage investments that aim to extend healthy human lifespan.
Hevolution Foundation is a global non-profit funder, partner, and impact-driven investor. It does not operate as a traditional university or laboratory. Instead, it supports researchers, institutions, entrepreneurs, and companies working to advance healthspan science and better understand the biology of aging.
Hevolution Foundation funds healthspan research, supports scientists, partners with leading institutions, and invests in biotechnology companies working to understand the biology of aging. Its goal is to accelerate science and innovation that can help extend healthy human lifespan.
About Healthspan Science
Healthspan science is the study of how people can live more years in good health. It focuses on understanding the biology of aging, preventing or delaying age-related decline, and developing research, therapies, technologies, and interventions that may help people maintain health and function for longer.
Healthspan is the number of years a person lives in good health, while lifespan is the total number of years a person lives. Hevolution Foundation focuses on advancing healthspan science so people can live longer lives with more years in good health, independence, and function.
Geroscience is the field that connects aging biology to clinical research and potential interventions. It uses what scientists learn about the biology of aging to explore ways to slow, delay, or reduce age-related decline and disease. Rather than treating diseases such as cancer, dementia, cardiovascular disease, diabetes, or frailty only as separate conditions, geroscience studies aging itself as a shared risk factor that may be targeted to improve healthspan.
Aging biology is the study of how and why the body changes with age at the molecular, cellular, and biological level. It focuses on the underlying mechanisms of aging, including DNA damage, mitochondrial dysfunction, cellular senescence, telomere shortening, inflammation, and changes in how cells repair and maintain themselves. Hevolution Foundation supports aging biology research because understanding these mechanisms is essential to advancing healthspan science.
Aging biology studies the mechanisms that drive aging. Geroscience applies that knowledge to research, clinical translation, and potential interventions that may improve healthspan. Put simply, aging biology helps explain how and why the body ages, while geroscience uses those insights to explore ways to delay age-related disease and help people live more years in good health.
Hevolution Foundation focuses on the biology of aging because aging is one of the greatest risk factors for many chronic diseases. By supporting research into the biological processes of aging, Hevolution aims to help shift healthcare from treating diseases after they appear to developing approaches that may preserve health and function for longer.
Aging is one of the greatest global challenges because people are living longer, but many spend more years with age-related diseases such as cardiovascular disease, cancer, dementia, diabetes, and frailty. As populations age, healthcare systems, economies, families, and workforces face growing pressure from the rising cost and impact of chronic disease.
Healthspan science matters because many healthcare systems are built to treat diseases after they appear. By studying the biology of aging, researchers may identify ways to delay or prevent multiple age-related diseases and help people maintain health, independence, and function for longer.
Healthspan science studies aging as a shared risk factor for many age-related diseases, rather than looking only at each disease separately. By understanding the biology of aging, researchers may identify ways to prevent, delay, or reduce the burden of multiple conditions, including cardiovascular disease, cancer, dementia, diabetes, and frailty.
About Funding, Grants, and Investments
Hevolution Foundation funds research in aging biology, geroscience, clinical research, and clinical trials. Its grant programs support scientists, research institutions, and selected biotech companies working to better understand the biology of aging and develop interventions that may help prevent or delay age-related decline.
Hevolution Foundation focuses on the biology of aging as a way to advance healthspan science. It combines grants, partnerships, convening, and early-stage biotech investments to support research and innovation across the healthspan ecosystem. This approach helps bring more scientists, institutions, companies, and investors into an underfunded field.
Healthspan research remains underfunded because most healthcare and research systems focus on treating individual diseases after they occur, rather than studying the biology of aging as a shared driver of many diseases. Hevolution Foundation is helping close this gap by allocating more than $400 million to research, grants, partnerships, and innovation focused on advancing healthspan science. Globally, less than 1% of research budgets focus on the biology of aging.
Eligibility depends on the specific Hevolution Foundation funding opportunity. Past and current programs have supported researchers, postdoctoral fellows, junior investigators, universities, research institutions, non-profit organizations, and selected biotech companies. Applicants should review each funding opportunity for eligibility, research focus, award amount, deadline, and application requirements.
Hevolution Foundation generally does not prioritize research focused only on specific diseases of older adults, the development of individual chronic diseases, or disease-specific animal models. Its focus is on aging biology, geroscience, and research that can improve understanding of aging as a biological process.
Yes. Hevolution Foundation invests in early-stage biotechnology companies developing therapies, platforms, and technologies that target the root causes of aging. These investments are part of Hevolution’s broader effort to accelerate healthspan science and help move promising discoveries toward real-world impact.
Biotechnology plays an important role in healthspan science by helping translate discoveries in aging biology into potential therapies, tools, platforms, and technologies. Hevolution Foundation invests in early-stage biotech companies working on approaches that target the root causes of aging and may help extend healthy human lifespan.
Hevolution Foundation uses grants and investments to support different parts of the healthspan ecosystem. Grants primarily support scientific research, academic institutions, non-profit research organizations, and selected research programs. Investments support early-stage companies developing therapies, technologies, and platforms that may help advance healthspan science.
Hevolution Foundation has allocated more than $400 million to advance healthspan science through research, grants, partnerships, and biotech investments. This funding supports the Foundation’s work to grow the field, support scientists, and accelerate innovation focused on extending healthy human lifespan.
About Global Collaboration & Convening
The Global Healthspan Summit focuses specifically on healthspan science, aging biology, geroscience, biotechnology, investment, and global collaboration. Rather than treating aging only as a healthcare or demographic issue, the Summit brings together the full ecosystem working to understand the biology of aging and extend healthy human lifespan.
The Global Healthspan Summit is important because it gives the emerging healthspan field a central platform for global collaboration. The Summit brings together scientists, investors, policymakers, entrepreneurs, healthcare leaders, and international organizations to share research, build partnerships, discuss investment, and move healthspan science toward greater real-world impact.
Yes. The Global Healthspan Summit is recognized by Hevolution Foundation as the world’s largest healthspan convening of its kind. Hosted in Riyadh, Saudi Arabia, the Summit brings together global leaders across science, medicine, biotechnology, investment, policy, entrepreneurship, and international organizations to advance healthspan science and accelerate action around healthy aging.
The Global Healthspan Summit helps move healthspan science from discussion to action by connecting research, investment, entrepreneurship, policy, and public awareness in one global platform. Hevolution describes the Summit as a platform for action designed to accelerate healthspan science, empower the next generation of scientists, increase public awareness, and support a paradigm shift in the healthspan ecosystem.
Hevolution Foundation hosts the Global Healthspan Summit to accelerate healthspan science and bring the global ecosystem together around one shared challenge: helping people live longer lives in better health. The Summit creates a platform for scientific exchange, partnership building, investment discussion, public awareness, and action-focused collaboration across the healthspan field.
The Global Healthspan Summit brings together leaders from across the healthspan ecosystem, including scientists, researchers, policymakers, venture capitalists, biotech companies, pharmaceutical companies, healthcare leaders, international organizations, entrepreneurs, and innovators. The Summit is designed to connect the people and institutions working to advance aging biology, geroscience, healthspan science, and healthy aging.
The Global Healthspan Summit covers healthspan science, aging biology, geroscience, biotechnology, investment, entrepreneurship, healthcare innovation, public awareness, and the social and economic impact of aging. The Summit also explores how science, technology, policy, and capital can work together to help advance healthy aging and extend healthy human lifespan.
The Global Healthspan Summit supports healthspan science by bringing together the people and organizations needed to move the field forward. It creates space for scientists to share research, investors to understand emerging opportunities, entrepreneurs to connect with partners, and policymakers to engage with the health and economic implications of aging populations.
About The Global Healthspan Report
The Global Healthspan Report is a Hevolution Foundation publication that examines the state of healthspan science, aging research, investment, innovation, policy, and global action. The report helps scientists, policymakers, investors, healthcare leaders, and other stakeholders understand why healthy aging should be treated as a scientific, economic, and societal priority.
Hevolution Foundation publishes the Global Healthspan Report to help build understanding, urgency, and alignment around healthspan science. The report provides data, analysis, and perspective on the progress of the field, the need for greater investment, and the opportunity to shift from treating disease after it appears to supporting healthier aging earlier in life.
The 2025 Global Healthspan Report states that global funding for healthspan science nearly doubled in 2024 to $7.33 billion, with average deal sizes increasing by 77% compared with the previous year. Hevolution says this growth signals rising investor confidence in healthspan science as an emerging sector.
The Global Healthspan Report supports Hevolution Foundation’s mission by helping define the healthspan field, track global momentum, and make the case for more research, investment, policy attention, and collaboration. It gives Hevolution a recurring platform to explain why extending healthy years of life matters for individuals, healthcare systems, economies, and societies.




